Bàn tròn SEC: Thành công, Thất bại và Các bước tiếp theo

Pilot Biotechnology

company

About

Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.

  • 501 - 1000

Details

Last Funding Type
Series C
Industries
Biopharma,Biotechnology,Health Care,Manufacturing,Medical,Pet
Founded date
Jan 1, 2015
Number Of Employee
501 - 1000
Operating Status
Active

Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzyme engineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥100M
Pilot Biotechnology has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Feb 8, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 8, 2022 Series C ¥100M 1 Lilly Asia Ventures Detail
Dec 16, 2021 Series C 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Pilot Biotechnology is funded by 2 investors. Lilly Asia Ventures and New Hope Sichuan Venture Capital Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures Yes Series C
New Hope Sichuan Venture Capital Fund Series C